Literature DB >> 6932503

Interaction of parotid saliva basic glycoprotein with Streptococcus sanguis ATCC 10557.

S Shibata, K Nagata, R Nakamura, A Tsunemitsu, A Misaki.   

Abstract

It is postulated that an initial step in dental plaque formation is the adherence of oral bacteria to the salivary pellicle. Recently, we have found that a proline-rich and basic glycoprotein (MGP) from human parotid saliva, which is successfully purified by Concanavalin A-Sepharose affinity chromatography, binds to some oral streptococci such as S. mitis and S. sanguis. This paper deals with some inhibitors which affect the binding of the MGP to S. sanguis ATCC 10557. The assay for the binding ability of the radioactive MGP to the bacterial cells was performed by incubation of the reaction mixture containing 10 microgram of [3H]MGP (6000 dpm) and about 4.5 mg of bacterial cells (dry weight) in 0.5 ml of 0.05 M Tris-HCl buffer containing 0.05 M NaCl, pH 8.0 with a final volume of 0.51 ml. After 1 hour standing at 4 degrees C, the cells were washed five times with the same buffer. The resulting sediment was solubilized in 0.5 ml of NCS tissue solubilizer and the radioactivity was measured. The binding of the radioactive MGP to bacterial cells was specifically inhibited by galactose, lactose and N-acetyllactosamine. Applications of heat and trypsin on the cell surface, strikingly reduced the binding ability. These findings strongly suggested that a lectin-like substance may be present on the bacterial cell surface.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932503     DOI: 10.1902/jop.1980.51.9.499

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  14 in total

1.  Interaction of the salivary low-molecular-weight mucin (MG2) with Actinobacillus actinomycetemcomitans.

Authors:  J Groenink; A J Ligtenberg; E C Veerman; J G Bolscher; A V Nieuw Amerongen
Journal:  Antonie Van Leeuwenhoek       Date:  1996-07       Impact factor: 2.271

2.  Adherence of oral streptococci to salivary glycoproteins.

Authors:  P A Murray; A Prakobphol; T Lee; C I Hoover; S J Fisher
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Aggregation of oral bacteria by human salivary mucins in comparison to salivary and gastric mucins of animal origin.

Authors:  H M Koop; M Valentijn-Benz; A V Nieuw Amerongen; P A Roukema; J de Graaff
Journal:  Antonie Van Leeuwenhoek       Date:  1990-11       Impact factor: 2.271

4.  Characterization of salivary alpha-amylase binding to Streptococcus sanguis.

Authors:  F A Scannapieco; E J Bergey; M S Reddy; M J Levine
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  Asparagine-linked carbohydrate chains of inducible rat parotid proline-rich glycoprotein contain terminal beta-linked N-acetylgalactosamine.

Authors:  G S Bedi
Journal:  Glycoconj J       Date:  1997-12       Impact factor: 2.916

Review 6.  Dental plaque as a biofilm.

Authors:  P D Marsh; D J Bradshaw
Journal:  J Ind Microbiol       Date:  1995-09

7.  Involvement of human mucous saliva and salivary mucins in the aggregation of the oral bacteria Streptococcus sanguis, Streptococcus oralis, and Streptococcus rattus.

Authors:  H M Koop; M Valentijn-Benz; A V Nieuw Amerongen; P A Roukema; J de Graaff
Journal:  Antonie Van Leeuwenhoek       Date:  1990-05       Impact factor: 2.271

8.  Positive coooperativity in the binding of Streptococcus sanguis to hydroxylapatite.

Authors:  W E Nesbitt; R J Doyle; K G Taylor; R H Staat; R R Arnold
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

Review 9.  Salivary proline-rich proteins.

Authors:  A Bennick
Journal:  Mol Cell Biochem       Date:  1982-06-11       Impact factor: 3.396

10.  Nuclear magnetic resonance spectroscopic and computer-stimulated structural analyses of a heptapeptide sequence found around the N-glycosylation site of a proline-rich glycoprotein from human parotid saliva.

Authors:  R E Loomis; K K Bhandary; C C Tseng; E J Bergey; M J Levine
Journal:  Biophys J       Date:  1987-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.